INTERNATIONAL PATENT: INDIAN INSTITUTE OF TECHNOLOGY BOMBAY, IMMUNOADOPTIVE CELL THERAPY PRIVATE LIMITED FILES APPLICATION FOR "NOVEL ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR, ITS NUCLEIC ACID SEQUENCE AND ITS PREPARATION"

GENEVA, Sept. 29 -- INDIAN INSTITUTE OF TECHNOLOGY BOMBAY (Powai, MaharashtraMumbai 400076), IMMUNOADOPTIVE CELL THERAPY PRIVATE LIMITED (First Floor, Plot R-977, TTC Industrial Area, MIDC Rabale, MaharashtraNavi Mumbai 400701) filed a patent application (PCT/IB2025/052672) for "NOVEL ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR, ITS NUCLEIC ACID SEQUENCE, AND ITS PREPARATION" on Mar 13, 2025. With publication no. WO/2025/196590, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PURWAR, Rahul Kailash (1515 Chittranjan Tower, Maharas...